Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Endothelial cell-released CD93 contributes to podocyte injury in idiopathic nephrotic syndrome.
Journal: Science translational medicine
Published: January 14, 2026
β1-Integrin blockade prevents podocyte injury in experimental models of minimal change disease.
Journal: Nefrologia
Published: August 03, 2022
Minimal Change Disease Is Associated With Endothelial Glycocalyx Degradation and Endothelial Activation.
Journal: Kidney international reports
Published: September 05, 2021
Use of Bortezomib in the Treatment of C3 Glomerulonephritis Refractory to Eculizumab and Rituximab.
Journal: Kidney international reports
Published: February 06, 2020
Vasculitis in a Child With the Hyper-IgM Variant of Ataxia-Telangiectasia.
Journal: Frontiers in pediatrics
Published: April 25, 2019
Urinary CD80: a biomarker for a favorable response to corticosteroids in minimal change disease.
Journal: Pediatric nephrology (Berlin, Germany)
Published: November 27, 2017
Effect of galactose on glomerular permeability and proteinuria in steroid-resistant nephrotic syndrome.
Journal: Pediatric nephrology (Berlin, Germany)
Published: April 17, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026